Impact of a PROgram of Cardiovascular Nurse interventionS in a VALVular haEmodynamic Unit (PROCESS-VALVE) on Quality Indicators: a Quasi-experimental Ambispective Study
1 other identifier
interventional
194
1 country
1
Brief Summary
The objective of this study is to evaluate the impact of a program of presurgical and postsurgical nurse interventions (PROCESS-VALVE) on quality indicators of the health of patients undergoing percutaneous valve procedures. (waiting times, patient satisfaction, admission times, hospital readmission, mortality, intrahospital complications and nosocomial infections). Design of the study is an ambispective quasi-experimental study. For the control group, data will be collected retrospectively from patients undergoing percutaneous valve procedures who did not receive pre- or postsurgical consultations. The intervention group will comprise those patients who agree to participate in the study and the haemodynamic nurse valve consultation program (PROCESS-VALVE). In addition, the investigators will assess whether a face-to-face postsurgical consultation improved quality indicators compared to postsurgical telephone consultation; for this, a sub-study will be carried out comparing face-to-face or telephone postsurgical follow-up by means of a randomised controlled clinical trial with simple blinding in the intervention group. Study area will be at the Hemodynamic Unit of the Hospital de la Santa Creu i Sant Pau and the study population are chosen patients for percutaneous valvular intervention who attend the pre-surgical consultation at our center. Dependent variable will be the indicators cited in the study aim and the independent variable will be the pre-surgical and post-surgical consultation. In pre-surgical consultation will be done a patient recruitment and will collect sociodemographic and clinical data. At patient will be done an individualized interview with an Ad-Hoc questionnaire and to collect fragility level of study and level of planned connections. In the subsequent follow-up, all pacients will receive a follow-up visit and collect satisfaction and quality indicators. But this pacients will be randomized to telephone follow-up or face-to-face follow up. Sample size has been calculated in 194 to be distributed equally in both groups and the clinical trials groups will be formed by 94 patients in each group The protocol has been modified to an ambispective quasi-experimental study with a subsequent randomization for the type of follow-up (telephone vs face-to-face) due to organizational changes in the participant center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 25, 2021
CompletedFirst Submitted
Initial submission to the registry
August 5, 2021
CompletedFirst Posted
Study publicly available on registry
January 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedNovember 18, 2025
May 1, 2023
3.3 years
August 5, 2021
November 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (13)
Waiting time
Time since Heart-team accepted until the intervention
Pre-intervention
Satisfaction assessed by SUCMA 14 Questionnaire
Use of an adaptation Sucma 14 Questionnaire (in english Questionnaire Satisfaction of Users of Major Ambulatory Surgery). This scale is former for 14 independent questions with 5 options response (likert scale)
One mounth after intervention
Satisfaction assessed by SUCMA 14 Questionnaire
Use of an adaptation Sucma 14 Questionnaire (in english Questionnaire Satisfaction of Users of Major Ambulatory Surgery). This scale is former for 14 independent questions with 5 options response (likert scale)
One year after intervention
Admission time
Time since intervention until hospital discharge
During hospital admission ( until the last day of admission)
Rate of Hospital readmission
Hospital readminission after the intervention for cardiac reasons
One mounth after intervention
Rate of Hospital readmission
Hospital readminission after the intervention for cardiac reasons
One year after intervention
Rate of Mortality
Mortality for all reasons (cardiac or other reason)
Into admission time
Rate of Mortality
Mortality for all reasons (cardiac or other reason)
One mounth after intervention
Rate of Mortality
Mortality for all reasons (cardiac or other reason)
One year after intervention
Rate of Intrahospital complications
Procedure complications (vascular, stroke and cardiac complication)
Into admission time
Rate of Intrahospital complications
Procedure complications (vascular, stroke and cardiac complication)
One mounth after intervention
Rate of Intrahospital complications
Procedure complications (vascular, stroke and cardiac complication)
One year after intervention
Rate of Nosocomial infection
Infection adquired during hospital admission
During hospital admission (until the last day of admission)
Study Arms (2)
Intervention Group: post-surgical face-to-face follow up consultation
EXPERIMENTALControl Group: post-surgical telephone follow up consultation
EXPERIMENTALInterventions
Follow-up face-to-face consultation or follow-up telephone consultation a month after the intervention and telephone consultation at one year
Eligibility Criteria
You may qualify if:
- Patients accepted for Heart-Team for percutaneous treatment aortic stenosis/insufficiency and mitral or tricuspid regurgitation
- Patients visited in the pre-surgical nursing consultation
You may not qualify if:
- Patients with language barrier
- Patients undergoing emergency surgery for percutaneous treatment aortic stenosis/insufficiency and mitral or tricuspid regurgitation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de la Santa Creu i Sant Pau
Barcelona, 08041, Spain
Related Publications (1)
Valverde Bernal J, Martinez-Soler F, Berga Congost G, Martinez Perez J, Asmarats L, Moreno Arroyo C. Impact of a PROgram of Cardiovascular nursE interventionS in a VALVular haEmodynamic Unit (PROCESS-VALVE) on Quality Indicators: A Quasi-Experimental Ambispective Study. Int J Gen Med. 2023 Sep 20;16:4257-4265. doi: 10.2147/IJGM.S412369. eCollection 2023.
PMID: 37750105DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2021
First Posted
January 5, 2022
Study Start
February 25, 2021
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
November 18, 2025
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share